SCP0005
MG-115 Peptide
≥95% (HPLC), lyophilized powder
Sign Into View Organizational & Contract Pricing
Select a Size
5 MG
MXP 4,196.00
MXP 4,196.00
Estimated to ship onApril 26, 2025
All Photos(1)
Select a Size
Change View
5 MG
MXP 4,196.00
About This Item
Empirical Formula (Hill Notation):
C25H39N3O5
Molecular Weight:
461.59
UNSPSC Code:
12352202
NACRES:
NA.32
MXP 4,196.00
Estimated to ship onApril 26, 2025
Recommended Products
Product Name
MG-115 / ASD 4955,
Assay
≥95% (HPLC)
form
lyophilized
composition
Peptide Content, ≥80%
storage condition
protect from light
storage temp.
−20°C
Amino Acid Sequence
Z-Leu-Leu-Nva-al
Application
MG-115 (Z-Leu-Leu-Nva-al) is used as a selective proteosome inhibitor.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Yolanda Pérez-Pertejo et al.
Parasitology, 138(9), 1082-1092 (2011-08-05)
Methionine adenosyltransferase (MAT) is an important enzyme for metabolic processes, to the extent that its product, S-adenosylmethionine (AdoMet), plays a key role in trans-methylation, trans-sulphuration and polyamine synthesis. Previous studies have shown that a MAT-overexpressing strain of Leishmania donovani controls
Estabelle Ang et al.
Journal of cellular physiology, 220(2), 450-459 (2009-04-15)
Proteasome inhibitors represent a promising therapy for the treatment of relapsed and/or refractory multiple myeloma, a disease that is concomitant with osteolysis and enhanced osteoclast formation. While blockade of the proteosome pathway has been recently shown to influence osteoclast formation
Karim Harhouri et al.
EMBO molecular medicine, 9(9), 1294-1313 (2017-07-05)
Hutchinson-Gilford progeria syndrome (HGPS) is a lethal premature and accelerated aging disease caused by a de novo point mutation in LMNA encoding A-type lamins. Progerin, a truncated and toxic prelamin A issued from aberrant splicing, accumulates in HGPS cells' nuclei
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
